about
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicityAntiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsyThe fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in miceModulation of anxiety through blockade of anandamide hydrolysisTransglutaminase-synthesized gamma-(glutamyl5) spermidine derivative of substance P is a selective tool for neurokinin-2 receptors characterization.Etodolac/cyclodextrin formulations: physicochemical characterization and in vivo pharmacological studies.Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized ratsThe nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.The endocannabinoid system as a target for therapeutic drugs.Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain.Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats.Control of pain initiation by endogenous cannabinoids.Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.Palmitoylethanolamide treatment reduces blood pressure in spontaneously hypertensive rats: involvement of cytochrome p450-derived eicosanoids and renin angiotensin system.Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs.Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infantsSynergistic antinociception by the cannabinoid receptor agonist anandamide and the PPAR-alpha receptor agonist GW7647.The search for the palmitoylethanolamide receptor.Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory.Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.Palmitoylethanolamide in CNS health and disease.Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation.Alginate-hyaluronan composite hydrogels accelerate wound healing process.Galactosyl prodrug of palmitoylethanolamide: synthesis, stability, cell permeation and cytoprotective activity.Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism.CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations.Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice.Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice.Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea.Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis.Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats.Dexamethasone modifies morphine-, atropine-, verapamil-induced constipation in mice.
P50
Q27305830-F313DF77-5020-44B6-A16A-DDC772236DA7Q28280535-738CAFC4-D7A6-404E-A679-0F6A1570B4C8Q28296777-7B22AADA-7961-43A5-9608-42B2A45E26A3Q29615902-6B003DD9-551D-4A84-83E9-F1ED5D7016DCQ32061436-25798894-B544-4A63-8E68-34FC12D06E26Q33452151-434425CA-098D-4A29-80AD-F545D7159071Q33569699-28CFCB25-696A-4360-9027-FF42BBC91638Q33844609-431FEA5D-DFAA-44EA-B66B-D0740C950E78Q33934278-C965557E-0DD0-4C44-B142-E6BE217FDC08Q33953174-F179E97E-B8AE-40FD-A845-E777CC64A6A3Q34183654-369280EA-01E7-4DBF-BD06-A0A46D48BEDFQ34213372-80A75266-4282-4F7C-85A2-94BA297C5B56Q34261073-763A6E2F-30E2-4500-82B5-02512ADFEE61Q34571255-A1A837A5-A102-4A6B-AB99-25412BD6FFF0Q34605811-09792AF0-7519-4F96-B410-D9EBFFA91744Q34749934-A724AEDA-DC1D-4C1D-B29D-9795913389B3Q34827887-E43998F8-FB42-4742-9E05-996369127A62Q35581957-464B2199-8929-4656-B3FF-07732F149D09Q35678770-EA518FAA-2754-41D2-B0C5-3540F7331136Q35750708-B94DA1B8-E8CC-4F84-83D6-358C73A4AF9EQ35783421-6CF1E1DC-57EC-4EAD-9A4D-7FFF73D532B8Q36019444-72D29E08-96F0-4C4E-BE92-197EB6D0375DQ36166614-8009ECA3-C3FE-4B2C-A1CB-36584035B1B0Q37345010-49D86D6B-7792-4B05-AEC2-11DAD4293DAAQ37835517-33A00510-A193-4240-9F2F-B8A07849674DQ38209324-A6701A31-954B-4CBE-B638-40E32206639EQ38213117-6AE942F3-BDB9-4EB9-95BA-23D67DA7E5C0Q38298687-D28F5AA6-ED9F-4BC9-8C29-29DDA48E18E9Q38845118-49E3AFAA-B482-4BCD-ACCC-0965C6C2E3E3Q38992485-729D8E74-BBCE-4A0A-8C3A-BA35DF6A917EQ39230043-A1906FBA-4801-4ACD-A5D3-631106A827D4Q39383482-235CA760-9475-4B8B-9714-811F42BFD4CDQ40773725-3BABCF12-D1FD-4BB3-A14E-5D5B7C5B2960Q40995492-A342088D-7125-491E-9FA5-E7A01B79A8BDQ41845952-CEECCC9E-152E-46BD-B38D-92C87ADEACD1Q42709676-42AE1F9B-9B39-4F48-BA10-511996E2D215Q43246952-AB619A9F-695D-4A6E-9E65-E7D37F34AB17Q43253272-5E559C76-6ED8-453B-9D3D-27EAEC4E73AFQ43713612-9136D696-E5DB-4802-91D6-E8B2CED2139CQ43759723-4CB1EE14-DF17-48C2-A9B9-6C06D44DB187
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Calignano
@ast
Antonio Calignano
@en
Antonio Calignano
@es
Antonio Calignano
@nl
type
label
Antonio Calignano
@ast
Antonio Calignano
@en
Antonio Calignano
@es
Antonio Calignano
@nl
prefLabel
Antonio Calignano
@ast
Antonio Calignano
@en
Antonio Calignano
@es
Antonio Calignano
@nl
P106
P1153
7003942979
P21
P31
P496
0000-0002-1742-3179